Form 4: O'Connor Reports Changes in Beneficial Ownership of LeMaitre Vascular Inc. Stock

John James O'Connor, a director at LeMaitre Vascular Inc., reports changes in beneficial ownership due to the acquisition of dividend equivalent rights.

Summary

• On March 27, 2025, John James O'Connor, a director of LeMaitre Vascular Inc. [LMAT], reported changes in beneficial ownership.
• The changes involve the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.
• These rights are economically equivalent to shares of the Issuer's common stock and vest proportionately with the associated awards.
• The dividend equivalent rights accrued from awards granted on December 12, 2022, December 8, 2023, and December 6, 2024.
• The total dividend equivalent rights acquired are 0.4803, 0.4803, 0.8214, 0.9838 and 1.001.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of dividend equivalent rights has a minor impact on shareholders as it relates to executive compensation.

Key Dates

Keywords

beneficial ownership, dividend equivalent rights, restricted stock units, performance share units, LMAT, LeMaitre Vascular, Form 4, O'Connor